Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Home
/
Trials
/
NCT00343174
NCT00343174
View on ClinicalTrials.gov
Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of Symptoms
PHASE3
Completed
INTERVENTIONAL
Timeline
Start Date
Not specified
Conditions
Brain Infarction
Cerebral Ischemia
Acute Stroke
Interventions
DRUG
Ancrod
All Listed Sponsors
lead
Heidelberg University
OTHER
NCT00343174 - Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of Symptoms | Biotech Hunter | Biotech Hunter